| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_043b6544ffdad0d03e9469eefdcf5836 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2003-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0145b9a732a667c070ed54259624e187
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c44bc75a105654c6b441ba2dd228eee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10a394f8fbee02c4760559d9578278e6 |
| publicationDate |
2005-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1506012-A1 |
| titleOfInvention |
Use of a vaccine for active immunization against cancer |
| abstract |
The invention relates to the use of a vaccine that is based on a tumor-associated antigen, the epitope, mimotope, and specific or anti-idiotypic antibody thereof for producing a medicament used for prophylactic and/or therapeutic active immunization against cancer in combination with chemotherapy. |
| priorityDate |
2002-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |